Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
Clinical trial NCT07479979 · RECRUITING
Trial details
- NCT number
- NCT07479979
- Sponsor
- Natalie Callander
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.